METHOD FOR PREDICTING THERAPEUTIC EFFICACY OF PI3K/AKT/mTOR INHIBITOR ON BASIS OF PHLDA1 OR PIK3C2B EXPRESSION

摘要

An object of the present invention is to provide a chemotherapy using a PI3K/AKT/mTOR inhibitor that exhibits excellent antitumor effect on cancer patients. Chemotherapy using an anti-tumor agent containing a PI3K/AKT/mTOR inhibitor in a cancer patient based on the expression level of PHLDA1 and/or PIK3C2B in a biological sample containing tumor cells collected from a cancer patient How to predict the effectiveness of treatment.